Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

The canine atopic dermatitis treatment market is set to experience notable growth, with an expected increase from USD ...

Pharmaceutical firms are urged to capitalise on current trends in AD trials. The atopic dermatitis (AD) market is projected ...

Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...

Zenrelia is one of several drugs Elanco has in its pipeline that it predicts could reach blockbuster status, which in animal ...

Mycosis fungoid (MF), the most prevalent cutaneous T-cell lymphoma, frequently remains undiagnosed in its early stages due to ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals ( VNDA -6.06%). The commercial-stage ...

The FDA announced earlier today that ilunocitinib tablets (Zenrelia; Elanco) has received its approval. The latest drug from ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

The oral drug, Zenrelia, aims to control pruritus, or itching, associated with allergic dermatitis and to control atopic ...

On the other hand, according to the National Eczema Foundation, it can cause irritation in some people with atopic dermatitis (eczema). This is far more likely to happen when there's a higher urea ...

The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.